All these observations support the notion that the increased DN-Tem frequency observed in peripheral blood CD8+ Tem in NSCLC patients was primarily due to increase of clonally diverse GZMK+.DN-Tem population. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.